Fig. 2From: Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic optionsMutational profiling of YST-R. A Tumor mutational burden score (TMB) and microsatellite instability score (MSI) found in six cisplatin-resistant YST samples. B Pearson’s correlation plot of TMB and MSI. C List of identified individual and common genomic alterations found in six cisplatin-resistant YST tissuesBack to article page